| Disease Information | ||||||
|---|---|---|---|---|---|---|
| Disease Name | Gene Name | Type | UMLS | Association Type | Score | Source |
| Neurotoxicity Syndrome | BCL2L1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | ADRA1B | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | MTOR | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | NQO1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | TIMP3 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | CASP3 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | CRISPLD2 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | ST8SIA1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | ALOX5AP | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | BCHE | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | CD3D | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | CYP3A5 | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | RNASE6 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | ABCB1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | PRKCD | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | PLAT | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | NFE2L2 | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | PON1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | FOS | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | ADCYAP1 | group | C0235032 | Therapeutic | 0.3 | disgenet |
| Neurotoxicity Syndrome | P2RX1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | CCK | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | GABRR2 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | ADD3 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | SRSF5 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | EGLN1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | PTGES3 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | TGM1 | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | LAT | group | C0235032 | Biomarker | 0.3 | disgenet |
| Neurotoxicity Syndrome | SLC18A2 | group | C0235032 | Biomarker | 0.2 | disgenet |
| Neurotoxicity Syndrome | DRD2 | group | C0235032 | Biomarker | 0.2 | disgenet |
| Neurotoxicity Syndrome | EPHA4 | group | C0235032 | Biomarker | 0.2 | disgenet |
| Neurotoxicity Syndrome | IL10 | group | C0235032 | Therapeutic | 0.2 | disgenet |
| Neurotoxicity Syndrome | CAT | group | C0235032 | Biomarker | 0.2 | disgenet |
| click here to return to the previous page | ||||||